Tumor Heterogeneity and Drug Resistance

Join a robust array of experts from MIT and beyond who seek to better understand patient-specific variation in cancer progression and response to therapy.

We cordially invite scientists, oncologists, and any other member of the biomedical community to join us in a day of engaging talks, stimulating conversations with colleagues, and of course camaraderie in our collective fight against cancer. As we explore issues ranging from divergent single-cell states and plasticity to mechanisms of resistance through signaling and epigenetics, please consider joining us at this year’s summer symposium hosted by MIT’s nationally recognized basic cancer center.

Keynote speaker:

Cédric Blanpain
Université Libre de Bruxelles

Presentations by:

Rameen Beroukhim
Dana-Farber Cancer Institute and Harvard Medical School

Katherine Chiappinelli
George Washington University

Karuna Ganesh
Memorial Sloan Kettering Cancer Center

Paul Mischel
Stanford University

Neal Rosen
Memorial Sloan Kettering Cancer Center

Sydney Shaffer
University of Pennsylvania

Alex Shalek 
Koch Institute at MIT

Michael Yaffe
Koch Institute at MIT